Singulex couples robust microparticle-based immunoassays with proprietary single-molecule counting technology that improves assay sensitivity and extends dynamic measuring range 1 to 3 orders of magnitude greater than that could be achieved before. With the Erenna® Immunoassay System, even the smallest changes in biomarker levels can be measured, allowing researchers to gain unprecedented insights into complex disease biology, drug efficacy and drug safety.